Presentation at plenary session on clinical trials will highlight initial clinical data from ongoing ADCElerate1 trial in patients with advanced soft tissue sarcoma Copenhagen, Denmark, November 10, 2026 – Adcendo ApS (“Adcendo”), a biotech company focused on developing a pipeline of differentiated antibody-drug conjugates (ADCs) for cancers with high unmet medical need, today announced a […]